Accepted for Publication: February 1, 2021.
Published Online: May 6, 2021. doi:10.1001/jamaoncol.2021.0580
Corresponding Author: Willemien J. van Driel, MD, PhD, Center for Gynecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands (w.v.driel@nki.nl).
Author Contributions: Drs van Stein and van Driel had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: van Stein, Aalbers, Sonke.
Acquisition, analysis, or interpretation of data: van Stein, Aalbers, van Driel.
Drafting of the manuscript: van Stein, Aalbers.
Critical revision of the manuscript for important intellectual content: Aalbers, Sonke, van Driel.
Administrative, technical, or material support: van Stein, Aalbers.
Supervision: Aalbers, Sonke, van Driel.
Conflict of Interest Disclosures: Dr Sonke reported receiving institutional research support from AstraZeneca, Merck & Co, Inc, Novartis AG, and F. Hoffman–La Roche Ltd outside the scope of this review. No other disclosures were reported.
Additional Contributions: The Figure is reprinted with permission from LMC Vos, Netherlands Cancer Institute, all rights reserved.